Skip to main content
Log in

Liver Stiffness Measurement, Better than APRI, Fibroindex, Fib-4, and NBI Gastroscopy, Predicts Portal Hypertension in Patients with Cirrhosis

  • Original Paper
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

Liver stiffness measurement (LSM) is frequently used as non-invasive alternative for liver fibrosis including cirrhosis, which can lead to portal hypertension. This study was conducted to evaluate the predictive value of LSM in cirrhosis-induced portal hypertension patients. Between July 2011 and December 2013, 153 participants were enrolled into a single-center, prospective, cross-sectional study. Each subject received both gastroscopy and LSM. Baseline biochemical, APRI, Fibroindex, and Fib-4 were also performed. LSM of cirrhosis patients with portal hypertension was significantly higher compared to those without portal hypertension (P < 0.05). A LSM ≥ 13.6 kPa had a sensitivity of 83.87 % and a specificity of 72.53 % with an accuracy of 77.1 for the prediction of portal hypertension, which are higher than those of APRI, Fib-4, and Fibroscan separately. A combination of Fibroscan combined with Fib-4 achieved a maximum AUC of 0.833 and accuracy of 77.8. Discriminant and internal validation analysis showed that Fibroscan plus APRI obtained a lower false negative rate compared to Fibroscan plus Fib-4 and Fibroscan plus Fibroindex (9.68, 17.74, and 11.29 %, respectively). A good relationship was found between LSM and NBI mean optical density both by linear and polynomial correlation analysis (r = 0.5533 and r = 0.7349, both P < 0.001). There was a trend toward a better performance of LSM for assessing portal hypertension compared with NBI gastroscopy mean optical density (P = 0.028 and P = 0.05, respectively). Better than APRI, Fibroindex, Fib-4, and NBI gastroscopy, LSM can predict portal hypertension in cirrhosis patients. A LSM of 13.6 kPa can be considered to be the predictive value for portal hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Colecchia, A., Montrone, L., Scaioli, E., et al. (2012). Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis. Gastroenterology, 143(3), 646–654.

    Article  PubMed  Google Scholar 

  2. Hong, W. K., Kim, M. Y., Baik, S. K., et al. (2013). The usefulness of non-invasive liver stiffness measurements in predicting clinically significant portal hypertension in cirrhotic patients: Korean data. Clinical and Molecular Hepatology, 19(4), 370–375.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Suk, K. T., Baik, S. K., Yoon, J. H., et al. (2012). Revision and update on clinical practice guideline for liver cirrhosis. Korean Journal of Hepatology, 18(1), 1–21.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Zhao, C. Q., Zhou, Y., Ping, J., et al. (2014). Traditional Chinese medicine for treatment of liver diseases: progress, challenges and opportunities. Journal of Integrative Medicine, 12(5), 401–408.

  5. de Franchis, R., & Baveno V Faculty. (2010). Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. Journal of Hepatology, 53(4), 762–768.

    Article  PubMed  Google Scholar 

  6. Vizzutti, F., Arena, U., Romanelli, R. G., et al. (2007). Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology, 45(5), 1290–1297.

    Article  PubMed  Google Scholar 

  7. Sandrin, L., Tanter, M., Gennisson, J. L., et al. (2002). Shear elasticity probe for soft tissues with 1-D transient elastography. IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control, 49(4), 436–446.

    Article  PubMed  Google Scholar 

  8. Bureau, C., Metivier, S., Peron, J. M., et al. (2008). Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Alimentary Pharmacology & Therapeutics, 27(12), 1261–1268.

    Article  CAS  Google Scholar 

  9. Lemoine, M., Katsahian, S., Ziol, M., et al. (2008). Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis. Alimentary Pharmacology & Therapeutics, 28(9), 1102–1110.

    Article  CAS  Google Scholar 

  10. Foucher, J., Chanteloup, E., Vergniol, J., et al. (2006). Diagnosis of cirrhosis by transient elastography (FibroScan): A prospective study. Gut, 55(3), 403–408.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Kazemi, F., Kettaneh, A., N’kontchou, G., et al. (2006). Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. Journal of Hepatology, 45(2), 230–235.

    Article  PubMed  Google Scholar 

  12. Crisan, D., Radu, C., Lupsor, M., et al. (2012). Two or more synchronous combination of noninvasive tests to increase accuracy of liver fibrosis assessment in chronic hepatitis C; results from a cohort of 446 patients. Hepat Mon, 12(3), 177–184.

    Article  PubMed Central  PubMed  Google Scholar 

  13. Wai, C. T., Greenson, J. K., Fontana, R. J., et al. (2003). A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology, 38(2), 518–526.

    Article  PubMed  Google Scholar 

  14. Koda, M., Matunaga, Y., Kawakami, M., et al. (2007). FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology, 45(2), 297–306.

    Article  PubMed  Google Scholar 

  15. Zhai, X. F., Chen, Z., Li, B., et al. (2013). Traditional herbal medicine in preventing recurrence after resection of small hepatocellular carcinoma: a multicenter randomized controlled trial. Journal of Integrative Medicine, 11(2), 90–100.

  16. Ling, C. Q., Wang, L. N., Wang, Y., et al. (2014). The roles of traditional Chinese medicine in gene therapy. Journal of Integrative Medicine, 12(2), 67–75.

  17. Bayraktar, Y., Balkanci, F., Uzunalimoglu, B., et al. (1996). Is portal hypertension due to liver cirrhosis a major factor in the development of portal hypertensive gastropathy? American Journal of Gastroenterology, 91(3), 554–558.

    CAS  PubMed  Google Scholar 

  18. de Franchis, R. (2005). Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. Journal of Hepatology, 43(1), 167–176.

    Article  PubMed  Google Scholar 

  19. The French METAVIR Cooperative Study Group (1994). Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology, 20(1 Pt 1), 15–20.

  20. Ziol, M., Handra-Luca, A., Kettaneh, A., et al. (2004). Non-invasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology, 41, 48–54.

    Article  Google Scholar 

  21. Castera, L., Vergniol, J., Foucher, J., et al. (2005). Prospective comparison of transient elastography. Fibrotest, APRI and liver biopsy for the assessment of liver fibrosis in chronic hepatitis C. Gastroenterology, 128, 343–350.

    Article  PubMed  Google Scholar 

  22. Carrion, J. A., Navasa, M., Bosch, J., et al. (2006). Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transplantation, 12, 1791–1798.

    Article  PubMed  Google Scholar 

  23. Vallet-Pichard, A., Mallet, V., Nalpas, B., et al. (2007). Fib-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology, 46(1), 32–36.

    Article  CAS  PubMed  Google Scholar 

  24. Shi, K. Q., Fan, Y. C., Pan, Z. Z., et al. (2013). Transient elastography: A meta-analysis of diagnostic accuracy in evaluation of portal hypertension in chronic liver disease. Liver International, 33(1), 62–71.

    Article  PubMed  Google Scholar 

  25. Jung, H. S., Kim, Y. S., Kwon, O. S., et al. (2008). Usefulness of liver stiffness measurement for predicting the presence of esophageal varices in patients with liver cirrhosis. Korean Journal of Hepatology, 14(3), 342–350. (in Korean).

    Article  PubMed  Google Scholar 

  26. Song, H. Y., Zhang, L., Pan, J. L., et al. (2013). Bioactivity of five components of Chinese herbal formula Jiangzhi granules against hepatocellular steatosis. Journal of Integrative Medicine, 11(4), 262–268.

  27. Hisabe, T., Yao, K., Beppu, T., et al. (2013). Validity of the usefulness of microvascular architecture and microsurface structure using magnifying endoscopy with narrow-band imaging in the colorectal neoplasm. Annals of Gastroenterology, 26(1), 45–51.

    PubMed Central  PubMed  Google Scholar 

  28. Song, J., Zhang, J., Wang, J., et al. (2014). Meta-analysis: Narrow band imaging for diagnosis of gastric intestinal metaplasia. PLoS ONE, 9(4), e94869.

    Article  PubMed Central  PubMed  Google Scholar 

  29. Dong, S., & Su, S. B. (2014). Advances in mesenchymal stem cells combined with traditional Chinese medicine therapy for liver fibrosis. Journal of Integrative Medicine, 12(3), 147–155.

    Article  PubMed  Google Scholar 

  30. Huang, C. (2014). Natural modulators of liver X receptors. Journal of Integrative Medicine, 12(2), 76–85.

Download references

Acknowledgments

The authors thank Lüjin Li of Shanghai University of Traditional Chinese Medicine for his invaluable help with the statistical analysis.

Conflict of Interest

The authors declare that they have no competing interests.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Changquan Ling or Lingtai Wang.

Additional information

Wei Zhang and Liqiong Wang contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, W., Wang, L., Wang, L. et al. Liver Stiffness Measurement, Better than APRI, Fibroindex, Fib-4, and NBI Gastroscopy, Predicts Portal Hypertension in Patients with Cirrhosis. Cell Biochem Biophys 71, 865–873 (2015). https://doi.org/10.1007/s12013-014-0275-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-014-0275-z

Keywords

Navigation